Etonogestrel 68MG 1S
Ended Awarded
- Contract number
- SPE2DR26FBTCY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,217
Award facts
- Contract value 100% obligated
- $26,217.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $26,217.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Etonogestrel 68mg contraceptive devices. The award was made on November 13, 2025, under a firm fixed-price contract structure with an ultimate completion date of December 3, 2025. This delivery order was issued without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. As the prime contractor, DMS Pharmaceutical Group will deliver the pharmaceutical product directly to support Department of Defense medical supply requirements, with no subcontractors identified in the award documentation.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to ensure consistent pharmaceutical supply to military healthcare facilities worldwide. The parent IDC, designated contract SPE2DR, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, structured as a 30-month base period with three 30-month option periods. This framework enables the agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products including prescription medications, biologics, and medical consumables to support recurring medical supply needs of the Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FBTCY?
SPE2DR26FBTCY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FBTCY worth?
The government has obligated $26,217 on SPE2DR26FBTCY.
Is contract SPE2DR26FBTCY an order under another contract?
Yes. SPE2DR26FBTCY is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTCY competed?
The extent of competition for SPE2DR26FBTCY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award